Amgen Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +9.1%
EBITDA: +9.2%
EBIT: +58.2%
EPS: +31.0%
Free cash flow: -21.2%
Operating cash flow: -11.8%

Forward estimates

Revenue: +2.7%
EBITDA: +3.2%
EPS: +58.4%

Three-year CAGR

Revenue: +11.8%
EBITDA: +11.6%
EBIT: +3.7%
Net income: +5.6%
EPS: +5.6%
Free cash flow: -2.7%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.